Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 31 studies | 32% ± 17% | |
| pericyte | 15 studies | 39% ± 21% | |
| smooth muscle cell | 15 studies | 39% ± 19% | |
| oligodendrocyte precursor cell | 14 studies | 48% ± 19% | |
| glutamatergic neuron | 13 studies | 63% ± 23% | |
| GABAergic neuron | 11 studies | 57% ± 22% | |
| astrocyte | 11 studies | 46% ± 22% | |
| oligodendrocyte | 11 studies | 26% ± 14% | |
| capillary endothelial cell | 9 studies | 33% ± 9% | |
| fibroblast | 8 studies | 24% ± 9% | |
| mast cell | 8 studies | 28% ± 7% | |
| neuron | 7 studies | 40% ± 13% | |
| retinal ganglion cell | 7 studies | 51% ± 21% | |
| endothelial cell of vascular tree | 7 studies | 32% ± 15% | |
| interneuron | 6 studies | 63% ± 21% | |
| amacrine cell | 6 studies | 43% ± 19% | |
| cardiac muscle cell | 6 studies | 67% ± 22% | |
| endothelial cell of artery | 6 studies | 21% ± 3% | |
| endothelial cell of lymphatic vessel | 6 studies | 25% ± 10% | |
| type II pneumocyte | 6 studies | 22% ± 7% | |
| monocyte | 6 studies | 31% ± 7% | |
| retinal cone cell | 5 studies | 50% ± 21% | |
| mesothelial cell | 5 studies | 46% ± 19% | |
| vein endothelial cell | 5 studies | 33% ± 23% | |
| adipocyte | 5 studies | 22% ± 3% | |
| type I pneumocyte | 5 studies | 32% ± 10% | |
| granule cell | 4 studies | 58% ± 13% | |
| retinal bipolar neuron | 4 studies | 30% ± 13% | |
| OFF-bipolar cell | 4 studies | 41% ± 19% | |
| ON-bipolar cell | 4 studies | 44% ± 17% | |
| ciliated cell | 4 studies | 34% ± 17% | |
| GABAergic interneuron | 3 studies | 61% ± 5% | |
| microglial cell | 3 studies | 41% ± 18% | |
| dendritic cell | 3 studies | 17% ± 1% | |
| non-classical monocyte | 3 studies | 31% ± 15% | |
| GABAergic amacrine cell | 3 studies | 57% ± 20% | |
| glycinergic amacrine cell | 3 studies | 42% ± 10% | |
| retina horizontal cell | 3 studies | 40% ± 15% | |
| rod bipolar cell | 3 studies | 65% ± 23% | |
| hepatocyte | 3 studies | 44% ± 25% | |
| muscle cell | 3 studies | 44% ± 31% | |
| ependymal cell | 3 studies | 32% ± 19% | |
| alveolar macrophage | 3 studies | 34% ± 11% | |
| club cell | 3 studies | 34% ± 16% | |
| brush cell | 3 studies | 40% ± 13% | |
| podocyte | 3 studies | 74% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 4312.05 | 2566 / 2642 | 98% | 15.80 | 692 / 705 |
| pancreas | 99% | 1958.96 | 324 / 328 | 93% | 7.69 | 166 / 178 |
| breast | 100% | 4060.15 | 459 / 459 | 89% | 8.21 | 999 / 1118 |
| prostate | 96% | 2759.15 | 235 / 245 | 86% | 4.89 | 432 / 502 |
| kidney | 99% | 3300.08 | 88 / 89 | 81% | 6.15 | 730 / 901 |
| lung | 99% | 4379.88 | 575 / 578 | 71% | 4.09 | 821 / 1155 |
| thymus | 99% | 2877.45 | 648 / 653 | 71% | 3.01 | 427 / 605 |
| bladder | 100% | 5145.29 | 21 / 21 | 68% | 5.27 | 344 / 504 |
| liver | 88% | 1649.62 | 198 / 226 | 77% | 3.76 | 312 / 406 |
| stomach | 99% | 2533.84 | 357 / 359 | 62% | 3.39 | 178 / 286 |
| intestine | 92% | 3365.15 | 888 / 966 | 52% | 2.50 | 272 / 527 |
| esophagus | 77% | 3296.84 | 1117 / 1445 | 60% | 3.10 | 109 / 183 |
| uterus | 99% | 3394.06 | 169 / 170 | 35% | 2.00 | 160 / 459 |
| skin | 79% | 2620.63 | 1423 / 1809 | 51% | 2.25 | 239 / 472 |
| ovary | 78% | 1649.41 | 140 / 180 | 41% | 1.48 | 175 / 430 |
| adrenal gland | 21% | 244.74 | 54 / 258 | 84% | 7.51 | 193 / 230 |
| adipose | 100% | 5079.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 10423.51 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.65 | 1 / 1 |
| heart | 99% | 5714.15 | 855 / 861 | 0% | 0 | 0 / 0 |
| spleen | 99% | 2175.90 | 239 / 241 | 0% | 0 | 0 / 0 |
| muscle | 95% | 2514.59 | 763 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 68% | 1179.24 | 630 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 38% | 1.78 | 11 / 29 |
| eye | 0% | 0 | 0 / 0 | 31% | 1.36 | 25 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 1.03 | 10 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1904428 | Biological process | negative regulation of tubulin deacetylation |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0031175 | Biological process | neuron projection development |
| GO_0005813 | Cellular component | centrosome |
| GO_0005938 | Cellular component | cell cortex |
| GO_0000922 | Cellular component | spindle pole |
| GO_0030427 | Cellular component | site of polarized growth |
| GO_0004857 | Molecular function | enzyme inhibitor activity |
| Gene name | FRY |
| Protein name | Alternative protein FRY FRY microtubule binding protein Protein furry homolog |
| Synonyms | C13orf14 |
| Description | FUNCTION: Plays a crucial role in the structural integrity of mitotic centrosomes and in the maintenance of spindle bipolarity by promoting PLK1 activity at the spindle poles in early mitosis. May function as a scaffold promoting the interaction between AURKA and PLK1, thereby enhancing AURKA-mediated PLK1 phosphorylation. . |
| Accessions | ENST00000542859.6 Q5TBA9 H0YE00 A0A2R8Y5V8 A0A2R8YCY2 ENST00000647500.1 ENST00000642040.1 A0A2R8Y7Y8 A0A286YFA9 ENST00000645780.1 ENST00000436046.1 ENST00000477712.2 ENST00000643293.1 B1ALA1 L8EB55 |